반응식
[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]([C:13]2[CH:14]=[N:15][C:16]([N:19]3[CH2:24][CH2:23][N:22]([C:25]([O:27][C:28]([CH3:31])([CH3:30])[CH3:29])=[O:26])[CH2:21][CH2:20]3)=[N:17][CH:18]=2)([CH2:11][OH:12])[CH2:9]O)=[CH:4][CH:3]=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.N(C(OC(C)C)=O)=NC(OC(C)C)=O>C1COCC1.CN(C([S-])=S)C.CN(C([S-])=S)C.[Zn+2]>[F:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2([C:13]3[CH:14]=[N:15][C:16]([N:19]4[CH2:20][CH2:21][N:22]([C:25]([O:27][C:28]([CH3:30])([CH3:31])[CH3:29])=[O:26])[CH2:23][CH2:24]4)=[N:17][CH:18]=3)[CH2:9][O:12][CH2:11]2)=[CH:6][CH:7]=1참가 물질
6
반응물 3
생성물 1
시약·촉매·용매 2
반응 조건
- 온도
- 40 °C
실험 절차
A mixture of tert-butyl 4-(5-(2-(4-fluorophenyl)-1,3-dihydroxypropan-2-yl)pyrimidin-2-yl)piperazine-1-carboxylate (650 mg, 1.5 mmol), triphenylphosphine (470 mg, 1.8 mmol), diisopropyl azodicarboxylate (360 mg, 1.8 mmol) and ziram (500 mg, 1.8 mmol) in THF (50 mL) was heated at 40° C. overnight under N2 and concentrated. The residue was diluted with EtOAc (40 mL), washed with water (50 mL*2) and brine, dried over Na2SO4 and concentrated. The residue was purified by Prep-HPLC to give the desired product (35 mg, yield 6%) as a white solid. MS (ES+) C22H27FN4O3 requires: 414. found 359 [M+H−56]+; purity: 93% (UV214).
후처리
- concentrationconcentrated
- additionThe residue was diluted with EtOAc (40 mL)
- washwashed with water (50 mL*2) and brine
- dry with materialdried over Na2SO4
- concentrationconcentrated
- customThe residue was purified by Prep-HPLC
출처 및 근거
- ORD 기록
- ord-2de6eec56cbc40fab365c834fa35452f
- 출처 데이터셋
- uspto-grants-2015_12
- 특허 번호
- US09200002B2
연결된 노트
불러오는 중…